Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dessislava Marinova

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Folia Medica|February 14, 2024
A rare variation of superior rectus muscleDimo Stoyanov, Meglena Angelova, Dessislava Marinova
Frontiers in Cellular and Infection Microbiology|December 24, 2013
ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the questionNacho Aguiló, Dessislava Marinova, Carlos Martín, et al.
Journal of Visualized Experiments : Jove|September 30, 2016
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in MiceSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|November 8, 2013
Recent developments in tuberculosis vaccinesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Frontiers in Immunology|January 13, 2018
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB EpidemicJesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|April 28, 2017
MTBVAC from discovery to clinical trials in tuberculosis-endemic countriesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Microbiology Spectrum|July 16, 2017
Breaking Transmission with Vaccines: The Case of TuberculosisJesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova, et al.
Vaccine|July 9, 2021
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCGCarlos Martín, Dessislava Marinova, Nacho Aguiló, et al.
Plos One|April 8, 2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Peerj|February 20, 2016
On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesSergio Arregui, Joaquín Sanz, Dessislava Marinova, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Folia Medica|February 14, 2024
A rare variation of superior rectus muscleDimo Stoyanov, Meglena Angelova, Dessislava Marinova
Frontiers in Cellular and Infection Microbiology|December 24, 2013
ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the questionNacho Aguiló, Dessislava Marinova, Carlos Martín, et al.
Journal of Visualized Experiments : Jove|September 30, 2016
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in MiceSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|November 8, 2013
Recent developments in tuberculosis vaccinesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Frontiers in Immunology|January 13, 2018
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB EpidemicJesus Gonzalo-Asensio, Dessislava Marinova, Carlos Martin, et al.
Expert Review of Vaccines|April 28, 2017
MTBVAC from discovery to clinical trials in tuberculosis-endemic countriesDessislava Marinova, Jesus Gonzalo-Asensio, Nacho Aguilo, et al.
Microbiology Spectrum|July 16, 2017
Breaking Transmission with Vaccines: The Case of TuberculosisJesus Gonzalo-Asensio, Nacho Aguilo, Dessislava Marinova, et al.
Vaccine|July 9, 2021
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCGCarlos Martín, Dessislava Marinova, Nacho Aguiló, et al.
Plos One|April 8, 2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In VivoSantiago Uranga, Dessislava Marinova, Carlos Martin, et al.
Peerj|February 20, 2016
On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesSergio Arregui, Joaquín Sanz, Dessislava Marinova, et al.
Pageof 3